Quest Diagnostics Incorporated Profile Avatar - Palmy Investing

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical …
Medical - Diagnostics & Research
US, Secaucus [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
42.03 41.41 41.48 40.88 39.46 37.63 37.85 38.58 38.79 34.59 34.80 38.50 39.02 34.74 32.00
Profit Margin
9.78 9.78 6.27 7.53 11.88 7.48 9.46 8.58 10.01 9.77 11.11 15.16 18.49 9.57 9.23
Operating Margin
18.23 17.58 13.25 16.27 20.64 13.22 18.67 16.99 15.11 14.62 15.93 20.89 22.07 14.45 14.60
EPS Growth
30.77 4.35 -27.70 18.31 59.89 -31.36 28.46 -6.91 22.93 -3.91 17.93 67.40 48.88 -48.93 -6.53
Return on Assets (ROA)
8.51 8.45 5.05 5.99 9.49 5.63 7.12 6.39 7.35 6.69 6.68 10.20 14.66 7.37 6.09
Return on Equity (ROE)
18.28 17.87 12.74 13.35 21.50 12.93 15.14 13.94 15.69 14.11 15.21 21.17 30.96 16.05 13.54
Return on Invested Capital (ROIC)
11.97 11.82 7.64 9.95 12.75 8.43 11.11 9.24 10.25 9.71 8.65 13.05 16.52 10.68 9.44
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
36.29 35.07 43.22 36.23 37.24 38.09 36.65 36.97 36.03 35.38 41.49 33.19 34.22 36.01 34.70
Debt/Equity
77.89 74.14 108.99 80.80 84.40 87.47 77.95 80.68 76.90 74.64 94.45 68.87 72.27 78.43 77.15
Debt/EBITDA
156.02 160.91 295.76 201.88 238.98 269.03 225.51 248.16 251.34 267.28 261.77 145.22 119.85 237.96 261.62
Debt/Capitalization
43.78 42.57 52.15 44.69 45.77 46.66 43.80 44.65 43.47 42.74 48.57 40.78 41.95 43.96 43.55
Interest Debt per Share USD
17.49 17.85 26.44 22.25 22.97 27.08 26.42 27.69 28.72 29.85 41.07 35.96 38.46 41.03 44.80
Debt Growth
0.78 -3.77 34.60 -16.43 -0.94 12.91 -2.95 2.27 1.34 2.88 36.86 -12.63 0.04 -0.75 16.16
Liquidity
Current Ratio
158.55 132.21 89.75 149.02 122.17 93.80 127.96 156.07 123.56 93.60 125.13 172.18 156.36 122.37 130.69
Quick Ratio
128.55 106.61 68.63 110.98 91.78 65.77 88.15 130.99 100.38 77.24 113.32 150.79 134.28 97.36 104.46
Cash Ratio
50.44 37.00 10.56 28.22 16.52 11.23 11.34 36.60 12.96 9.09 59.90 65.20 49.74 20.31 37.80
Operating Cash Flow Ratio
- - - - - - 100 - - - - - - 100 100 - - - - 100 100 100 - -
Turnover
Inventory Turnover
4,728.12 5,636.03 4,933.00 4,688.19 4,753.85 4,215.46 5,544.05 5,629.27 4,967.37 4,975.76 4,095.12 2,602.69 3,162.98 3,359.38 3,311.05
Receivables Turnover
901.15 871.75 828.52 851.51 838.73 797.75 831.63 811.56 834.31 744.17 726.81 620.86 750.21 827.03 764.63
Payables Turnover
2,084.39 2,031.68 2,041.10 2,144.32 1,676.74 1,804.28 1,669.18 1,768.58 2,106.70 2,218.92 1,915.21 1,301.35 1,842.86 1,990.74 462.91
Asset Turnover
87.06 86.41 80.64 79.52 79.86 75.28 75.22 74.41 73.40 68.44 60.16 67.28 79.26 76.99 65.98
Coverage
Interest Coverage
943.16 886.72 583.24 729.08 927.67 599.39 914.38 893.01 771.52 659.28 703.43 1,209.20 1,576.82 1,034.78 888.82
Asset Coverage
200 200 100 200 200 200 200 200 200 200 200 200 200 200 200
Cash Flow Coverage (CFGR)
32.10 37.39 22.25 35.29 19.57 24.93 22.19 28.63 31.05 30.82 23.33 43.07 47.95 37.17 26.14
EBITDA Coverage
1,100 1,000 700 900 800 800 1,000 900 900 800 900 1,400 2,000 1,300 1,100
Dividend Coverage
-600 -600 -700 -500 -400 -200 -300 -200 -300 -200 -300 -400 -600 -300 -200
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 200 200 100 100
Market Prospects
Dividend Yield
0.98 1.14 0.70 1.17 2.27 1.92 2.07 1.73 1.83 2.35 2.00 1.86 1.43 1.68 2.03
Earnings Yield
6.50 7.60 5.11 6.01 10.43 5.72 6.92 5.01 5.72 6.50 6.00 8.96 9.23 5.21 5.53
Price/Earnings (P/E)
1,539.52 1,315.37 1,957.95 1,663.06 958.55 1,748.87 1,444.87 1,994.73 1,747.81 1,538.68 1,667.82 1,115.92 1,084.02 1,918.29 1,808.26
Price/Book (P/B)
281.35 235.10 249.51 221.99 206.13 226.08 218.71 278.00 274.19 217.12 253.68 236.26 335.60 307.94 244.85
Price/Sales (P/S)
150.56 128.68 122.68 125.18 113.88 130.78 136.72 171.20 175.03 150.37 185.22 169.21 200.47 183.62 166.91
Price/Cash Flow (P/CF)
1,125.39 848.17 1,028.94 778.50 1,248.17 1,036.64 1,264.71 1,203.55 1,148.35 943.73 1,151.24 796.45 968.48 1,056.29 1,214.04
End of DGX's Analysis
CIK: 1022079 CUSIP: 74834L100 ISIN: US74834L1008 LEI: - UEI: -
Secondary Listings